Recognition of Self-Generated Facial Emotions Is Impaired in Schizophrenia
Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
Abstract
Individuals with schizophrenia have difficulties in recognizing facial emotions in others. This study investigated whether this impairment also exists for self-generated expressions. Nineteen patients with schizophrenia and 19 comparison subjects were filmed while producing facial expressions in response to a visual model or a written sentence. After 2 months, all subjects were asked to rate their own emotional expressions. These ratings were compared with the evaluations of 12 healthy independent raters. With respect to the comparison subjects, the patients produced less expressive responses and were less able to recognize their own expressions. Moreover, patients were totally unaware of these impairments.
Impaired social interactions are a key characteristic of schizophrenia. It is tempting to relate this deficit to the well-known inability of patients with schizophrenia to recognize others' emotions.1 Although, there is still no consensus regarding the nature of this inability,2 gender does not seem to be a key factor.3 Also, when using Ekman's classification of primary emotions, no differences seem to appear between various emotions.4,5 It does not appear that some emotions are more affected than others.6
Patients with schizophrenia are not only deficient in recognizing facial emotions; they are also impaired in producing them. Flat affect is a frequent symptom in schizophrenia (66% of patients).7 This symptom has been extensively reported in the literature, under a wide range of contexts and stimuli (for reviews: see Kring and Moran8 and Morris et al.9), even in drug-naïve patients.10 However, a review of today's literature shows that no research has studied the ability of patients with schizophrenia to evaluate their own self-generated facial expressions. The present study aims to bring a new light to the understanding of evaluation of facial emotions in schizophrenia.
MATERIALS AND METHODS
Subjects
Nineteen patients with schizophrenia were enrolled in the study, recruited from Le Vinatier Hospital. There were all inpatients of the psychiatric unit. All patients met DSM-IV criteria for schizophrenia without other concurrent diagnosis. All of the patients were taking antipsychotic medication monotherapy (without change in the 2 preceding weeks), were clinically stable at the time of the experiment, and had been so for at least 4 weeks. A trained clinician (CD) administered the SAPS (Scale for the Assessment of Positive Symptoms)11 and SANS (Scale for the Assessment of Negative Symptoms)12 measurements to obtain ratings for positive and negative symptoms.
Healthy participants (N=19) were free of any Axis I diagnosis, Axis II cluster (schizotypal, schizoid, or paranoid personality disorder) and family history of psychiatric illness. Exclusion criteria included mood disorders (manic or depressive symptoms), neurological disorders, and any medical condition that might alter cerebral functioning. Healthy participants were matched to patients by age, gender, ethnicity, and education. Written informed consent was obtained from all participants after complete information was given.
Twelve healthy individuals also volunteered to rate the expressions produced by the patients and control subjects. These independent raters (mean age: 25.8 [standard deviation{SD}]: 11.6 years) were eligible for the study only if they did not know the subjects tested in the first phase of the experiment and did not work in a hospital, a mental health institution, or a research center.
Procedure
The study was divided into two phases. The first phase was a Production phase: participants had to produce facial emotions in response to a visual model or a written sentence. The second phase (Rating) began after 2 months: participants had to rate the expression they had produced in the first phase. Twelve independent raters also performed the rating of these expressions.
Production Phase
All participants were seated 60 cm. in front of a computer screen, above which there was a digital video camera (Sony HDR-SR1E). The camera recorded, uninterruptedly, the face of the subjects. The experimenter stood 1.50 meters behind the participant and could not see his or her face. This phase was divided into two separate tests:
1.
Imitation of facial expressions: For this first test, subjects viewed six photographs of facial expressions and had to imitate them; 12 black-and-white pictures (19 cm. high and 13 cm. wide), showing faces expressing five emotions (happiness, anger, disgust, fear, and sadness) and neutrality were used. The expressive pictures were taken from Ekman's picture set.4 The neutral pictures were taken from a database used and validated in a previous experiment.13 The pictures were randomly presented across subjects. The instructions were to “Imitate the facial expressions you are about to see as an actor would do and do so only with your face.” When the subjects were satisfied with their imitation, they had to rate the intensity of the expression they had just produced on a scale from 1 (very low intensity) to 5 (very high intensity).
2.
Production of facial expressions from a written command (mime): For the second test, the participants saw a sentence on the screen defining an emotion and its related context (for example, fear: “A burglar enters your apartment; you are afraid.”). They had to mime the emotion “as an actor would do, and only with their face.” The emotions were presented to each participant in the same order as the one used for the first test. After each mime, the subjects had to rate the intensity of their expression on the same scale as the one used for the imitation test.
Recognition Phase
Evaluation of Self-Generated Facial Expressions
Two months after Phase 1, the participants were shown the 12 videos of their imitations and mimes. The videos lasted between 1 sec. and 5 sec., depending on the length of the emotional production. The 12 videos were presented in a random order. After each video, a rating screen appeared with five numbers (1 to 5), and the participants had to enter the perceived intensity of their own expressions on the keyboard (1: low; 5: high). Then, they had to determine which emotion was displayed in the video. For each trial, the list of possible emotions to choose from (happiness, anger, disgust, sadness, fear, neutrality) was displayed on a screen that appeared just after the validation of the intensity rating. The subject selected his or her response by using the keyboard. They were told at the beginning of the experiment that a given emotion could occur more than once. In the final step, the intensity rating screen was presented again, and participants were asked to report how confident they were about their recognition (1: not sure at all; to 5: absolutely sure). There was no time constraint, and the participants were free to take as much time as they wanted.
Evaluation of Emotional Productions by Independent Raters
Twelve raters viewed the facial expressions collected from all participants in Phase 1. The 456 videos collected from the control subjects and patients were randomly presented in two sessions of 45 minutes each (228 videos/session). These sessions took place on two different days. The videos were divided between the two sessions in such a way that 1) each emotion was presented the same number of times in each session; 2) each subject appeared the same number of times; and 3) there was the same number of videos associated with the imitation and mime conditions. The rating procedure (intensity, nature of the emotion, confidence) was the same as the one described above for the self-evaluation task.
Data Analysis
We performed 2×2×6 ANOVAs, with Group (Patients, Controls) as a between-subject variable and Production mode (Imitation, Mime) and emotion (Happiness, Anger, Disgust, Fear, Sadness, Neutrality) as within-subject variables. Fisher's least significant different test (Fisher's LSD) was used for post-hoc comparisons of the mean.
RESULTS
The demographic characteristics of the patients and control subjects are presented in Table 1.
Production Phase
The self-reported ability of patients and control subjects to produce facial expressions was not statistically different (group factor, main effect, and interactions, all p>0.05; F [1, 60]=1.66). All participants rated their expressions as more intense in the Mime condition than in the Imitation one (3.4 versus 3.1; F [1, 36]=11.76; p<0.01). The main effect of emotion was also significant (F [5, 180]=28.65; p<0.0001), indicating that some expressions were more difficult to produce than others (Sadness and Neutral condition).
Recognition Phase
Intensity
The ability of the patients and control subjects to rate the intensity of the facial expressions they had performed 2 months earlier was not statistically different (group factor, main effect, and interactions: F [1, 36]=0.94).
Accuracy/Confidence
The main effect of the group factor was significant (F [1, 36]=18.96; p<0.001), indicating that the patients were impaired at recognizing self-generated facial expressions (correct recognitions: Patients: 49.6%; Controls: 75.4%).
For confidence, a significant interaction was found between emotion and group (F [5, 180]=4.61; p<0.001). This interaction was due to the fact that the control subjects had more difficulties recognizing happiness than the patients (Fisher's LSD, all ps<0.001). However, for a given emotion, no significant difference was found between patients and controls (Fisher's LSD, all ps>0.05).
Ratings During Recognition Phase by Independent Judges
Intensity
The main effect of group was significant (F [1, 36]=13.70; p<0.001). The independent judges rated the facial emotions expressed by Patients as less intense than those expressed by Controls (2.7 versus 3.1).
Accuracy/Confidence
The main effect of group was significant (F [1, 36]=11.16; p<0.01). The independent judges were less accurate at recognizing the emotions expressed by the Patients than those expressed by the Controls (correct answers: 52.0% versus 65.4%). For confidence, the main effect of the group factor was significant (F [1, 36]=13.06; p<0.001). The independent judges were less confident about their answers for Patients than for Controls (3.3 versus 3.6, respectively). An interaction was found between group and emotion (F [5, 180]=2.39; p<0.001). It accounted for the fact that the magnitude of the differences observed between the Controls and the Patients was larger for some emotions than for others.
DISCUSSION
The aim of the present study was to bring new light to the understanding of how patients with schizophrenia assess self-generated facial emotions.
This study shows that patients with schizophrenia are impaired, as compared with control subjects, at recognizing their own facial expressions on videos. Interestingly the patients are totally unaware of this impairment, and they are as confident as healthy subjects in their ability to recognize these expressions. These results are in line with previous observations showing that patients with schizophrenia are dramatically impaired at recognizing the facial expressions performed by others.14
One explanation that can be given is that the inability of the patients to recognize their own expression could be related, at least partially, to their lack of facial expressiveness. Indeed, in agreement with previous studies, we found that patients with schizophrenia were significantly less expressive than control subjects.15–17 Strikingly, independent judges 1) rated the patients' facial expressions as less intense than the expressions produced by control subjects; 2) were less accurate at recognizing emotions expressed by the patients with respect to the controls; and 3) were less confident in their responses about the patients' expressions.
Although patients with schizophrenia have difficulty in expressing their emotion at a facial level, they report experiencing as much positive and negative emotion as the control subjects.7 As a consequence, it seems that the lack of facial expressiveness of patients misrepresents their actual emotional experience. Consistent with this idea, we showed that the patients were as confident as the control subjects in their ability to express the emotions they wanted to convey and recognize these emotions on videos. However, a major difference between the controls and the patients lies in the fact that the control subjects were capable of recognition when they were unsure about an expression. This was not the case for the patients, who reported the same level of confidence for their right and wrong recognitions.
Thus, it seems that the patients acted as if they had a fixed confidence level for all their judgments. Overall, these results are consistent with recent data showing that preserved implicit emotion contrasts with impairments to explicit emotion-classification in schizophrenia.18 Thus, the major result of our study is that patients with schizophrenia seem not to be aware of their impairment in facial expressiveness. Such an unawareness of impairment has also been reported in several domains, for example, in assessment of their cognitive impairment level,19 functional disabilities,20 and decision-making skills.21 This lack of awareness, that could hypothetically be caused by impaired self-monitoring,22 may then be a core aspect of schizophrenia.
A limitation of the present study lies in the fact that we did not considered other components of emotional expression, such as voice pitch or hand/body gestures. These dimensions could be worth considering in further studies. In the same way, it could be important to investigate self-recognition in other psychiatric pathologies, including depression. Indeed, depressed patients have been reported to be as impaired as patients with schizophrenia in posed emotional expression.
This being said, one may also argue that our results were affected by the fact that the subjects had different (uncontrolled) cultural backgrounds. Although plausible in theory, this hypothesis seems unlikely, considering that all participants lived in France and that the six facial expressions assessed in our study are known to be cross-culturally comparable. In the same way, one may claim that our conclusions were affected by the fact that the patients were treated with antipsychotic medication. Again, this does not seem to be a likely possibility, considering that the lack of expressiveness in patients with schizophrenia is independent of antipsychotic treatment,10 especially for the second-generation antipsychotic monotherapy that was used in the present study.
In summary, patients with schizophrenia show a generalized impairment in their ability to recognize and express facial emotions. This deficit is likely to have dramatic consequences on interpersonal relationships. It may be a partial explanation for the social-cognition disabilities of these patients. The observed lack of facial expressiveness among the patients contradicts their perception that their emotional expressions are normal. This may be one aspect of the expression of Bleuler's Spaltung.23 Developing cognitive remediation strategies that would aim specifically at the impairment of expressing and recognizing facial expressions could be a promising mode for the treatment of schizophrenia.24,25
Acknowledgments
The authors are grateful to Gabrielle Chesnoy for editing the manuscript.
References
1.
Addington J, Girard TA, Christensen BK, et al.: Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. J Psychiatry Neurosci 2010; 35:49–54
2.
Andreasen NC: Affective flattening and the criteria for schizophrenia. Am J Psychiatry 1979; 136:944–947
3.
Simons G, Ellgring JH, Beck-Dossler K, et al.: Facial expression in male and female schizophrenia patients. Eur Arch Psychiatry Clin Neurosci 2010; 260:267–276
4.
Ekman P, Frisen WV: Pictures of facial affect. Palo Alto, CA, Consulting Psychologists Press, 1976
5.
Ekman P, Hager JC, Friesen WV: The symmetry of emotional and deliberate facial actions. Psychophysiology 1981; 18:101–106
6.
Edwards J, Jackson HJ, Pattison PE: http://www.ncbi.nlm.nih.gov/pubmed/12214327: Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clinical Psychology Review 2002; 22:789–832. Review Erratum in: Clinical Psychology Review 2002; 22:1267–1285
7.
Kring AM, Kerr SL, Smith DA, et al.: Flat affect in schizophrenia does not reflect diminished subjective experience of emotion. J Abnorm Psychol 1993; 102:507–517
8.
Kring AM, Moran EK: Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull 2008; 34:819–834
9.
Morris RW, Weickert CS, Loughland CM: Emotional face processing in schizophrenia. Curr Opin Psychiatry 2009; 22:140–146
10.
Kring AM, Earnst KS: Stability of emotional responding in schizophrenia. Behav Ther 1999; 30:373–388
11.
Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa, The University of Iowa, 1983
12.
Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa, The University of Iowa, 1984
13.
Chambon V, Baudouin JY, Franck N: The role of configural information in facial emotion recognition in schizophrenia. Neuropsychologia 2006; 12:2437–2444
14.
Marwick K, Hall J: Social cognition of schizophrenia: a review of face processing. Br Med Bull 2008; 88:43–58
15.
Berenbaum H: Posed facial expressions of emotion in schizophrenia and depression. Psychol Med 1992; 22:929–937
16.
Gaebel W, Wölwer W: Facial expression and emotional face recognition in schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 1992; 242:46–52
17.
Flack WF, Cavallaro RA, Laird JD, et al.: Accurate encoding and decoding of emotional facial expressions in schizophrenia. Psychiatry 1997; 60:197–210
18.
Linden SC, Jackson MC, Subramanian L, et al.: Emotion-cognition interactions in schizophrenia: implicit and explicit effects of facial expression. Neuropsychologia 2010; 997–1002
19.
Keefe RS, Poe M, Walker TM, et al.: The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry 2006; 163:426–432
20.
Bowie CR, Twamley EW, Anderson H, et al.: Self-assessment of functional status in schizophrenia. J Psychiatr Res 2007; 41:1012–1018
21.
Koren D, Seidman LJ, Goldsmith M, et al.: Real-world cognitive—and metacognitive—dysfunction in schizophrenia: a new approach for measuring (and remediating) more “right stuff.” Schizophr Bull 2006; 32:310–326
22.
Farrer C, Franck N: Self-monitoring in schizophrenia. Curr Psychiatry Reviews 2007; 3:243–251
23.
Bleuler E: Dementia praecox oder Gruppe der Schizophrenien, 1911 in Groupe des schizophrénies. Trad. Eysenck H., GREC/EPEC, 2001
24.
Meyer MB, Kurtz MM: Elementary neurocognitive function, facial affect recognition, and social-skills in schizophrenia. Schizophr Res 2009; 110:173–179
25.
Demily C, Franck N: Cognitive remediation: a promising tool for the treatment of schizophrenia. Expert Rev Neurother 2008; 8:1029–1036
Information & Authors
Information
Published In
History
Received: 10 April 2010
Revision received: 27 September 2010
Accepted: 11 October 2010
Published online: 1 April 2011
Published in print: Spring 2011
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).